BIOMÉRIEUX |
Market Closed -
Other stock markets
|
After market 01:14:46 pm | |||
| 99 EUR | -1.10% |
|
98.62 | -0.38% |
| Apr. 10 | Stifel Reaffirms bioMérieux at Buy, Lifts PT | MT |
| Apr. 10 | BIOMÉRIEUX : Stifel raises target price | CF |
Chart calendar bioMérieux
d45770d5b78499386816c780fec3c4b._iRXeTzVfE5v6obtl0cnboZxxvYnAOThgDPZpSO_cac.nXciOHe0SAw7hMql5QNFWfc0gaBVdJaExmHs92GINvaaUjtND-YZAiWZ4Q~d194e1e4fbac0f20846d6ab3267d8d64
Upcoming events on bioMérieux
Past events on bioMérieux
| 2024-04-09 03:30 am | Capital Markets Day - Q1 2024 Sales and Revenue |
| 2024-04-09 01:00 am | Q1 2024 Sales and Revenue Release |
| 2024-03-14 09:30 am | Q4 2023 Earnings Call |
| 2024-03-14 02:00 am | Q4 2023 Earnings Release |
| 2023-10-26 09:00 am | Q3 2023 Sales and Revenue Call |
| 2023-10-26 01:00 am | Q3 2023 Sales and Revenue Release |
| 2023-09-01 08:00 am | Q2 2023 Earnings Call |
| 2023-09-01 01:00 am | Q2 2023 Earnings Release |
| 2023-06-05 | Ex-dividend day for final dividend |
| 2023-05-22 | Annual General Meeting |
| 2023-04-27 08:00 am | Q1 2023 Sales and Revenue Call |
| 2023-04-27 01:00 am | Q1 2023 Sales and Revenue Release |
| 2023-03-08 08:00 am | Q4 2022 Earnings Call |
| 2023-03-08 01:00 am | Q4 2022 Earnings Release |
| 2022-12-04 | Berenberg European Conference |
| 2022-10-26 09:00 am | Q3 2022 Sales and Revenue Call |
| 2022-10-26 01:00 am | Q3 2022 Sales and Revenue Release |
| 2022-08-31 08:30 am | Interim 2022 Earnings Call |
| 2022-08-30 | Interim 2022 Earnings Release |
| 2022-06-05 | Ex-dividend day for final dividend |
Past dividends on bioMérieux
| 2023-06-05 | Annual 0.85 EUR |
| 2022-06-05 | Annual 0.85 EUR |
| 2021-06-03 | Annual 0.62 EUR |
| 2020-07-13 | Annual 0.19 EUR |
| 2019-06-03 | Annual 0.35 EUR |
| 2018-06-04 | Annual 0.34 EUR |
| 2017-06-05 | Annual 1 EUR |
| 2016-06-06 | Annual 1 EUR |
| 2015-06-04 | 1 EUR |
| 2014-06-02 | Annual 1 EUR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2 675 2 642 1.23% | 3 118 3 131 -0.4% | 3 376 3 331 1.37% | 3 589 3 550 1.1% | 3 675 3 675 -0.01% | 3 907 |
|
EBITDA Million EUR | Released Forecast Spread | 578 572 0.95% | 824 782 5.34% | 1 032 954 8.19% | 864 873 -0.99% | 827 821 0.73% | 889 |
|
EBIT Million EUR | Released Forecast Spread | 371 387 -4.3% | 595 555 7.25% | 784 753 4.12% | 587 629 -6.59% | 439 547 -19.8% | 601 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 348 359 -3.12% | 524 510 2.71% | 774 726 6.58% | 581 618 -6.02% | 437 533 -18.01% | 617 |
|
Net income Million EUR | Released Forecast Spread | 273 278 -1.77% | 404 405 -0.13% | 601 560 7.26% | 452 483 -6.25% | 358 408 -12.21% | 471 |
|
EPS EUR | Released Forecast Spread | 2,30 2,34 -1.51% | 3,41 3,41 0.12% | 5,06 4,59 10.24% | 3,82 3,93 -2.88% | 3,01 3,45 -12.72% | 3,89 |
| Announcement Date | 26/02/20 | 24/02/21 | 02/03/22 | 07/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1 400 1 397 0.23% | 1 476 1 527 -3.34% | 1 642 1 611 1.94% | 1 574 1 601 -1.67% | 924 903 2.37% | 821 730 12.45% | 1 658 1 567 5.81% | 902 855 5.46% | 1 029 1 029 0.01% | 1 931 1 931 0.01% | 864 1 658 -47.87% | 1 770 1 774 -0.22% | 898 935 -3.95% | 1 006 1 022 -1.58% | 965 | 913 | 1 878 | 955 | 1 101 | 2 056 | |
|
EBIT Million EUR | Released Forecast Spread | 182 192 -5.59% | 244 223 9.27% | 351 329 6.82% | 366 297 23.01% | 297 320 -7.16% | 290 334 -13.12% | 322 | 208 300 -30.73% | 231 313 -26.18% | 265 | 321 | ||||||||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 305 320 -4.87% | 359 296 20.99% | 289 330 -12.39% | 262 | 318 | ||||||||||||||||
|
Net income Million EUR | Released Forecast Spread | 132 142 -7.09% | 173 173 0.23% | 232 245 -5.63% | 277 230 20.74% | 228 240 -5% | 224 255 -12.14% | 207 | 252 | |||||||||||||
|
EPS EUR | Released Forecast Spread | 1,11 1,16 -4.31% | 1,95 2,06 -5.34% | 2,33 1,93 20.73% | 1,89 2,15 -12.09% | 1,74 | 2,12 | |||||||||||||||
| Announcement Date | 26/02/20 | 02/09/20 | 24/02/21 | 01/09/21 | 02/03/22 | 31/08/22 | 31/08/22 | 26/10/22 | 07/03/23 | 07/03/23 | 31/08/23 | 31/08/23 | 14/12/23 | 14/03/24 | 14/03/24 | - | - | - | - | - | - |
More events
Past sector events for bioMérieux
| Today 02:00 am | VITROLIFE AB: Q1 2024 Earnings Release |
| 2024-04-15 | AMOY DIAGNOSTICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-11 | SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-09 01:00 am | BIOMÉRIEUX: Q1 2024 Sales and Revenue Release |
| 2024-03-29 | BEIJING STRONG BIOTECHNOLOGIES,INC.: Q4 2023 Earnings Release |
| 2024-03-27 | NEW HORIZON HEALTH LIMITED: Q4 2023 Earnings Release |
| 2024-03-27 02:30 am | SD BIOSENSOR, INC: Q4 2023 Earnings Release |
| 2024-03-22 | SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD: Q4 2023 Earnings Release |
| 2024-03-21 | SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-15 08:35 am | DIASORIN S.P.A.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIM Stock
- Calendar bioMérieux
